Phibro Animal Health Corporation PAHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 386.77M | 396.75M | 383.54M | 373.91M | 363.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 386.77M | 396.75M | 383.54M | 373.91M | 363.89M |
| Cost of Revenue | 258.24M | 270.85M | 257.87M | 240.42M | 242.99M |
| Gross Profit | 128.54M | 125.90M | 125.68M | 133.50M | 120.90M |
| SG&A Expenses | 78.19M | 81.27M | 77.50M | 78.50M | 72.05M |
| Depreciation & Amortization | -- | 2.40M | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 336.43M | 354.52M | 335.37M | 318.92M | 315.04M |
| Operating Income | 50.35M | 42.22M | 48.17M | 54.99M | 48.85M |
| Income Before Tax | 38.78M | 32.34M | 32.31M | 36.43M | 36.27M |
| Income Tax Expenses | 9.26M | 10.63M | 8.29M | 8.97M | 9.74M |
| Earnings from Continuing Operations | 29.52M | 21.71M | 24.02M | 27.46M | 26.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.52M | 21.71M | 24.02M | 27.46M | 26.53M |
| EBIT | 50.35M | 42.22M | 48.17M | 54.99M | 48.85M |
| EBITDA | 63.92M | 54.05M | 60.62M | 67.88M | 61.68M |
| EPS Basic | 0.73 | 0.53 | 0.59 | 0.68 | 0.65 |
| Normalized Basic EPS | 0.61 | 0.41 | 0.55 | 0.63 | 0.52 |
| EPS Diluted | 0.72 | 0.53 | 0.59 | 0.67 | 0.65 |
| Normalized Diluted EPS | 0.60 | 0.40 | 0.55 | 0.63 | 0.52 |
| Average Basic Shares Outstanding | 40.59M | 40.60M | 40.55M | 40.53M | 40.53M |
| Average Diluted Shares Outstanding | 40.96M | 41.00M | 41.04M | 40.96M | 40.88M |
| Dividend Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Payout Ratio | 16.50% | 22.42% | 20.26% | 17.71% | 18.34% |